Wearable ophthalmic Devices, Small Molecules
Total Trials
20
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,221
NCT00703183
Safety and Tolerability of ACU-4429
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2008
Completion: Jun 30, 2009
NCT00942240
Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects
Start: Jul 31, 2009
Completion: Apr 30, 2010
NCT01002950
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Phase: Phase 2
Start: Oct 31, 2009
Completion: Oct 31, 2012
NCT01027013
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
Start: Dec 31, 2009
Completion: Nov 30, 2010
NCT01057147
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
Start: Feb 28, 2010
Completion: Feb 28, 2011
NCT01410188
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Phase: Phase 1/2
Start: Sep 30, 2011
NCT01632137
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Phase: Phase 3
Start: Jun 30, 2012
Completion: Not specified
NCT01802866
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
Phase: Phase 2/3
Start: Feb 28, 2013
Completion: May 31, 2016
NCT02130531
Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
Start: Apr 30, 2014
Completion: Nov 30, 2015
NCT02753400
Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
Start: May 31, 2016
Completion: Dec 31, 2017
NCT03033108
Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
Start: Jan 31, 2017
NCT03772665
Safety and Efficacy of Emixustat in Stargardt Disease
Start: Jan 7, 2019
Completion: Jun 23, 2022
NCT04169802
Study Evaluating Retinal Health Monitoring System Visual Acuity Module.
Phase: N/A
Start: Nov 20, 2019
Completion: Apr 15, 2020
NCT04388020
Effects of Projected Peripheral Defocus on Ocular Biometrics
Start: Apr 11, 2020
Completion: May 14, 2020
NCT04428242
Study Evaluating Retinal Health Monitoring System Thickness Module
Start: Apr 30, 2020
Completion: Jul 31, 2020
NCT04415684
Projected Peripheral Defocus Using a Wearable Device
Start: Jun 29, 2020
Completion: Aug 20, 2020
NCT04499703
Evaluation of the Retinal Health Monitoring System Thickness Module
Start: Nov 11, 2020
Completion: Jan 25, 2021
NCT05425108
Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device
Start: Jun 23, 2022
Completion: Aug 31, 2023
NCT06034379
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Start: Oct 1, 2023
Completion: Dec 31, 2025
NCT06085430
Kubota Glass Parameter Refinement Study
Start: Nov 1, 2023
Completion: Sep 30, 2024
Loading map...